111 related articles for article (PubMed ID: 17607914)
1. Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract.
Höfler H; Langer R; Ott K; Keller G
Recent Results Cancer Res; 2007; 176():33-6. PubMed ID: 17607914
[TBL] [Abstract][Full Text] [Related]
2. Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract.
Höfler H; Langer R; Ott K; Keller G
Adv Exp Med Biol; 2006; 587():115-20. PubMed ID: 17163161
[TBL] [Abstract][Full Text] [Related]
3. Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma.
Langer R; Specht K; Becker K; Ewald P; Bekesch M; Sarbia M; Busch R; Feith M; Stein HJ; Siewert JR; Höfler H
Clin Cancer Res; 2005 Oct; 11(20):7462-9. PubMed ID: 16243820
[TBL] [Abstract][Full Text] [Related]
4. [Prediction of response to neoadjuvant chemotherapy in Barrett's carcinoma by quantitative gene expression analysis].
Langer R; Specht K; Becker K; Ewald P; Sarbia M; Busch R; Feith M; Stein HJ; Siewert JR; Höfler H
Verh Dtsch Ges Pathol; 2004; 88():207-13. PubMed ID: 16892554
[TBL] [Abstract][Full Text] [Related]
5. Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients.
Napieralski R; Ott K; Kremer M; Specht K; Vogelsang H; Becker K; Müller M; Lordick F; Fink U; Rüdiger Siewert J; Höfler H; Keller G
Clin Cancer Res; 2005 Apr; 11(8):3025-31. PubMed ID: 15837757
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pretherapeutic and posttherapeutic expression levels of chemotherapy-associated genes in adenocarcinomas of the esophagus treated by 5-fluorouracil- and cisplatin-based neoadjuvant chemotherapy.
Langer R; Specht K; Becker K; Ewald P; Ott K; Lordick F; Siewert JR; Höfler H
Am J Clin Pathol; 2007 Aug; 128(2):191-7. PubMed ID: 17638652
[TBL] [Abstract][Full Text] [Related]
7. [Multimodal therapy of tumors of the upper gastrointestinal tract].
Fink U; Stein HJ; Siewert JR
Chirurg; 1998 Apr; 69(4):349-59. PubMed ID: 9612616
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of the gene expression profile in residual tumor cells after neoadjuvant chemo-radiotherapy for esophageal cancer.
Tanaka K; Otake K; Mohri Y; Ohi M; Yokoe T; Toiyama Y; Miki C; Tonouchi H; Kusunoki M
Oncol Rep; 2009 Jun; 21(6):1489-94. PubMed ID: 19424628
[TBL] [Abstract][Full Text] [Related]
9. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.
Schneider S; Uchida K; Brabender J; Baldus SE; Yochim J; Danenberg KD; Salonga D; Chen P; Tsao-Wei D; Groshen S; Hoelscher AH; Schneider PM; Danenberg PV
J Am Coll Surg; 2005 Mar; 200(3):336-44. PubMed ID: 15737843
[TBL] [Abstract][Full Text] [Related]
11. ERCC1 expression and tumor regression predict survival in esophageal squamous cell carcinoma patients receiving combined trimodality therapy.
Ge H; Lu Y; Chen Y; Zheng X; Wang W; Yu J
Pathol Res Pract; 2014 Oct; 210(10):656-61. PubMed ID: 25042384
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients.
Fukuda H; Takiguchi N; Koda K; Oda K; Seike K; Miyazaki M
Cancer Invest; 2006; 24(3):235-41. PubMed ID: 16809149
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma.
Ott K; Vogelsang H; Mueller J; Becker K; Müller M; Fink U; Siewert JR; Höfler H; Keller G
Clin Cancer Res; 2003 Jun; 9(6):2307-15. PubMed ID: 12796400
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma.
Grundei T; Vogelsang H; Ott K; Mueller J; Scholz M; Becker K; Fink U; Siewert JR; Höfler H; Keller G
Clin Cancer Res; 2000 Dec; 6(12):4782-8. PubMed ID: 11156235
[TBL] [Abstract][Full Text] [Related]
16. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
Xi H; Baldus SE; Warnecke-Eberz U; Brabender J; Neiss S; Metzger R; Ling FC; Dienes HP; Bollschweiler E; Moenig S; Mueller RP; Hoelscher AH; Schneider PM
Clin Cancer Res; 2005 Dec; 11(23):8341-7. PubMed ID: 16322294
[TBL] [Abstract][Full Text] [Related]
17. Progress in the development of protein biomarkers of oesophageal and gastric cancers.
Coghlin C; Murray GI
Proteomics Clin Appl; 2016 Apr; 10(4):532-45. PubMed ID: 26582241
[TBL] [Abstract][Full Text] [Related]
18. [A complete response after neoadjuvant chemotherapy for advanced gastric cancer with esophageal invasion].
Yabusaki H; Nashimoto A; Tanaka O
Gan To Kagaku Ryoho; 2002 Jan; 29(1):119-23. PubMed ID: 11816467
[TBL] [Abstract][Full Text] [Related]
19. [A successful resected case of advanced esophageal cancer with early gastric cancer responding to neoadjuvant chemotherapy of docetaxel, CDDP and 5-FU].
Matsutani T; Yoshida H; Sasajima K; Maruyama H; Yokoyama T; Matsushita A; Hirakata A; Takao Y; Umakoshi M; Hayakawa T; Katayama H; Hosone M; Uchida E
Gan To Kagaku Ryoho; 2012 Apr; 39(4):645-8. PubMed ID: 22504694
[TBL] [Abstract][Full Text] [Related]
20. A quantitative evaluation of the determinant proteins for S-1 responsiveness in a biopsy specimen assists in patient selection to neoadjuvant therapy in cases of advanced gastric cancer.
Hashiguchi K; Kitajima Y; Kai K; Hiraki M; Nakamura J; Tokunaga O; Noshiro H; Miyazaki K
Int J Oncol; 2010 Aug; 37(2):257-64. PubMed ID: 20596652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]